A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

Completed · Phase 3 · Has a placebo group

Conditions studied: CKD Anemia

In brief

The purpose of this study is to determine whether roxadustat is safe and effective in the treatment of anemia in participants with chronic kidney disease and not on dialysis.

Key facts

Study ID

NCT01750190

Run by

Kyntra Bio

People needed

922

Starts

2012-11-05

Expected to finish

2018-09-24

Last updated by the study team

2021-10-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Chronic kidney disease Stages 3, 4, or 5 and not receiving dialysis
• Anemia qualified by measurements of hemoglobin values during screening
• Additional blood work must be in a safe range for study entry
• Body weight 45 to 160 kilograms (kg)
• Willingness to use contraception if of child-bearing potential

You may not qualify if…

• Treatment with an erythropoiesis-stimulating agent (ESA) within 12 weeks prior to study participation
• More than 1 dose of intravenous iron within 12 weeks prior to study participation
• Blood transfusion within 8 weeks prior to study participation
• Active infection
• Chronic liver disease
• Severe congestive heart failure, recent heart attack, stroke, seizure, or blood clot
• Uncontrolled blood pressure within 2 weeks prior to study participation
• Renal cell carcinoma
• History of malignancy, including multiple myeloma or other myelodysplastic syndrome
• Chronic inflammatory disease that could impact red blood cell production
• Any prior organ transplant or a scheduled organ transplantation
• Anticipated elective surgery that is expected to lead to significant blood loss or anticipated elective heart procedure
• Gastrointestinal bleeding
• Any prior treatment with roxadustat or a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI)
• Recent use of an investigational drug or treatment, or participation in an investigational study

Where it is running

• Investigational Site — Tempe, Arizona, United States
• Investigational Site — Alhambra, California, United States
• Investigational Site — Chula Vista, California, United States
• Investigational Site — Inglewood, California, United States
• Investigational Site — La Mesa, California, United States
• Investigational Site — La Palma, California, United States
• Investigational Site — Lynwood, California, United States
• Investigational Site — Northridge, California, United States
• Investigational Site — Paramount, California, United States
• Investigational Site — Riverside, California, United States
• Investigational Site — Roseville, California, United States
• Investigational Site — San Dimas, California, United States
• Investigational Site — Whittier, California, United States
• Investigational Site — Coral Gables, Florida, United States
• Investigational Site — Cutler Bay, Florida, United States
• Investigational Site — Hialeah, Florida, United States
• Investigational Site — Miami, Florida, United States
• Investigational Site — Miami, Florida, United States
• Investigational Site — Miami, Florida, United States
• Investigational Site — Miami, Florida, United States
• Investigational Site — Ocala, Florida, United States
• Investigational Site — Pembroke Pines, Florida, United States
• Investigational Site — South Miami, Florida, United States
• Investigational Site — Winter Park, Florida, United States
• Investigational Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.